Earlier this week, I attended a drop-in event to support the End Our Pain campaign to secure cannabis-based medication for children with severe epilepsy that does not respond to typical treatments.

Despite it now being three years since a legal change allowed cannabis-based products for medicinal use (CBPMs) to be prescribed in the UK, these are still rarely provided on the NHS. This can cost families up to £2,000 each month, as in reality, they usually struggle to obtain these products without a private prescription.

I have signed End Our Pain’s letter to the Prime Minister and Health Secretary, calling for immediate action to facilitate access to CBPMs via NHS prescriptions, for those with treatment-resistant epilepsy. I hope that the Government will now act to secure these treatments for these families who are at ‘emotional and financial breaking point.’